GlassScriptPhysician profile
Anna Bida-Dudun
NPI 1669444782
$402.24
in general payments reported to CMS, 2019-2025
11 companies · $65.71 in 2025
The $65.71 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102 · 2020: $31.70 · 2021: $64.34 · 2022: $69.53 · 2023: $36.54 · 2024: $32.10 · 2025: $65.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $134.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $99.66 | 2019-2022 | |
| Hologic Sales and Service, LLC | $65.23 | 2023-2025 | Fluent Fluid Management System, Affirm Prone Biopsy System, Aptima |
| Pacira Pharmaceuticals Incorporated | $64.34 | 2021 | |
| Organon LLC | $51.61 | 2022-2025 | Nexplanon, Nuvaring |
| Exeltis, USA INC. | $27.60 | 2022-2024 | Slynd |
| Therapeuticsmd, INC. | $20.94 | 2019 | |
| Abbvie INC. | $20.36 | 2022 | |
| Pfizer INC. | $17.55 | 2023 | |
| Radius Health, INC. | $12.61 | 2020 | |
| Boston Scientific Corporation | $11.47 | 2019 | |
| Allergan, INC. | $10.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Bida-Dudun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.